Abstract
The impact of clinical hypertension, however, is pointed out as a major predisposition to worsening, in with COVID-19 in this interaction still insufficiently investigated. The coronavirus disease 2019 (COVID-19) has become a worldwide responsible for a worldwide pandemic of deaths. Common hypertension has been identified as one of the comorbidities and risk factors for severity and adverse consequences. Recent investigations raise the question of hypertension a predictor of patients with COVID-19 independently of others such as chronic diseases, obesity, other cardiovascular diseases, kidney, liver and lung diseases. The purpose of this report was to provide a clinical view of hypertension in intensive care with or without the effect of blood pressure levels, the impact of previously known hypertension and the effect of antihypertensive therapy on severity and outcomes in patients with and without COVID-19.